Phase II Study of Gemcitabine, 5-Fluorouracil, and Leucovorin in Patients With Pancreatic Cancer

This publication has 14 references indexed in Scilit:

• Cancer statistics, 1998
  CA: A Cancer Journal for Clinicians, 1998
• Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer
  Annals of Oncology, 1996
• Preclinical characteristics of gemcitabine
  Anti-Cancer Drugs, 1995
• Phase II trial of gemcitabine (2,2′-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreas
  Investigational New Drugs, 1994
• Pancreatic Carcinoma
  New England Journal of Medicine, 1992
• A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma
  Cancer, 1991
• A phase III trial on the therapy of advanced pancreatic carcinoma evaluations of the mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin
  Cancer, 1990
• Continuous 5-Fluorouracil (5FU) Infusion in Carcinoma of the Pancreas: A Phase II Study
  The Lancet Healthy Longevity, 1988
• Randomized study of 5-FU and ccnu in pancreatic cancer: Report of the veterans administration surgical adjuvant cancer chemotherapy study group
  Cancer, 1981
• Chemotherapy in pancreatic cancer: results of a controlled, prospective, randomised, multicentre trial.
  BMJ, 1980